✦ LIBER ✦

Comparison of efficacy and toxicity between gemcitabine plus cisplatin and plus carboplatin in first-line treatment of advanced non-small cell lung cancer

✍ Scribed by Meiqi Shi; Bo Shen; Guochun Cao; Yun Zeng; Guohao Xia; Jifeng Feng; Lin Xu

Publisher: Springer
Year: 2008
Tongue: English
Weight: 80 KB
Volume: 7
Category: Article
ISSN: 1610-1979
DOI: 10.1007/s10330-008-0014-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical observation of docetaxel plus c

Clinical observation of docetaxel plus cisplatin versus gemcitabine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer

✍ Yongguang Cai; Ming Li; Xin Xie 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 216 KB

The efficacy and relationship between pe

The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer

✍ Linrun Wang; Xiuhua Wu; Mingzhu Huang; Jie Cai; Nong Xu; Jian Liu 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 234 KB

Phase II trial of a 2-h infusion of gemc

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

✍ N. Xu; P. Shen; X. C. Zhang; L. F. Yu; H. Y. Bao; G. M. Shi; S. Huang; J. Chen; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 302 KB

A phase II trial of weekly chemotherapy

A phase II trial of weekly chemotherapy with paclitaxel plus gemcitabine as a first-line treatment in advanced non-small-cell lung cancer

✍ Kiyoshi Mori; Hiroyuki Kobayashi; Yukari Kamiyama; Yasuhiko Kano; Tetsuro Kodama 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 268 KB

Randomized phase 2 study of irinotecan p

Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer

✍ Ji-Youn Han; Dae Ho Lee; Jung Eun Song; Sung Young Lee; Hyae Young Kim; Heung Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 145 KB 👁 1 views

A multicenter, randomized, Phase II stud

A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma

✍ Filippo De Marinis; Fabrizio Nelli; Marco Lombardo; Francesco Ferraú; Santi Barb 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to evaluate the activity and toxicity of combined cisplatin, etoposide, and gemcitabine (PEG) and combined cisplatin plus gemcitabine (PG) in previously untreated patients with extensive‐stage and poor‐prognosis limited‐stage small‐cell lun